An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

NCT00657176 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: OPB-31121

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.